Gene · 6300
Papers1,954
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,954
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combination of QSAR Modeling and Hybrid-Based Consensus Scoring to Identify Dual-Targeting Inhibitors of PLK1 and p38γ. | J Chem Inf Model | 2023 | 37883148 | PubTator, text mining | PubMed |
| Microbiota-derived imidazole propionate inhibits type 2 diabetic skin wound healing by targeting SPNS2-mediated S1P transport. | iScience | 2023 | 37876799 | PubTator, text mining | PubMed |
| Inhibition of SQSTM1 S403 phosphorylation facilitates the aggresome formation of ubiquitinated proteins during proteasome dysfunction. | Cell Mol Biol Lett | 2023 | 37872526 | PubTator, text mining | PubMed |
| Cellular pathogenesis of Duchenne muscular dystrophy: progressive myofibre degeneration, chronic inflammation, reactive myofibrosis and satellite cell dysfunction. | Eur J Transl Myol | 2023 | 37846661 | PubTator, text mining | PubMed |
| Sleeping Beauty transposon mutagenesis identified genes and pathways involved in inflammation-associated colon tumor development. | Nat Commun | 2023 | 37845228 | PubTator, text mining | PubMed |
| Distinct pleiotropic effects of direct oral anticoagulants on cultured endothelial cells: a comprehensive review. | Front Pharmacol | 2023 | 37841935 | PubTator, text mining | PubMed |
| Editorial: RNA machines. | Front Genet | 2023 | 37829284 | PubTator, text mining | PubMed |
| Senescence risk score: a multifaceted prognostic tool predicting outcomes, stemness, and immune responses in colorectal cancer. | Front Immunol | 2023 | 37828981 | PubTator, text mining | PubMed |
| A de novo missense mutation in MPP2 confers an increased risk of Vogt-Koyanagi-Harada disease as shown by trio-based whole-exome sequencing. | Cell Mol Immunol | 2023 | 37828081 | PubTator, text mining | PubMed |
| New insights of miRNA molecular mechanisms in breast cancer brain metastasis and therapeutic targets. | Noncoding RNA Res | 2023 | 37818447 | PubTator, text mining | PubMed |
| Common pathogenic bacteria-induced reprogramming of the host proteinogenic amino acids metabolism. | Amino Acids | 2023 | 37814028 | PubTator, text mining | PubMed |
| Isoform-specific optical activation of kinase function reveals p38-ERK signaling crosstalk. | RSC Chem Biol | 2023 | 37799579 | PubTator, text mining | PubMed |
| Fluid flow shear stress and tissue remodeling-an orthodontic perspective: evidence synthesis and differential gene expression network analysis. | Front Bioeng Biotechnol | 2023 | 37795174 | PubTator, text mining | PubMed |
| Revisiting p38 Mitogen-Activated Protein Kinases (MAPK) in Inflammatory Arthritis: A Narrative of the Emergence of MAPK-Activated Protein Kinase Inhibitors (MK2i). | Pharmaceuticals (Basel) | 2023 | 37765094 | PubTator, text mining | PubMed |
| Epithelial-Immune Cell Crosstalk Determines the Activation of Immune Cells In Vitro by the Human Cathelicidin LL-37 at Low Physiological Concentrations. | Biomolecules | 2023 | 37759716 | PubTator, text mining | PubMed |
| Inflammation-related signaling pathways in tendinopathy. | Open Life Sci | 2023 | 37744452 | PubTator, text mining | PubMed |
| Phosphoflow cytometry to assess cytokine signaling pathways in peripheral immune cells: potential for inferring immune cell function and treatment response in patients with solid tumors. | J Exp Clin Cancer Res | 2023 | 37741983 | PubTator, text mining | PubMed |
| Mechanism and recent updates on insulin-related disorders. | World J Clin Cases | 2023 | 37727490 | PubTator, text mining | PubMed |
| Analysis of the mechanism of action of Euphorbia fischeriana Steud on cirrhosis based on network pharmacology. | Medicine (Baltimore) | 2023 | 37713886 | PubTator, text mining | PubMed |
| Molecular and phenotypic spectrum of cardio-facio-cutaneous syndrome in Chinese patients. | Orphanet J Rare Dis | 2023 | 37697378 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6300/papers?page=7